News

How affordable are glaucoma interventions in developed and developing countries? Doug Katsev, MD, takes a look.

In this edition of the Medical News Minute, Doug Katsev, MD, shares the latest research regarding betadine use prior to cataract surgery

Latanoprostene bunod especially useful to patients who do not respond to first-line therapy

Novel platforms address adherence; clinicians look to efficacy, treatment duration

Here is one question to help clinicians decide: ‘What is the anatomy giving me?’

Exploring broad utility of netarsudil for ROCK inhibition across spectrum of glaucoma

CXL has potential to alter disease course; progression display plays role in when to intervene

Research to understand underlying mechanisms may lead to clues for targeted therapy

How an unforgettable patient could see-and speak out-again

Be excited about looking at the odds and following your team as they begin the long process of qualifying for playing in the World Series. Spring training is just around the corner and who doesn’t love a good ball game?

Ophthalmology Times’ Editorial Advisory Board members share their thoughts on what to watch in year ahead

Look beyond ocular surface dysfunction for clues, causes of dry eye pain

Read the latest Optic Relief from OT cartoonist Jon Carter.

Ophthalmology benefiting from active programs for innovative product development in 2018 and onward